Cargando…

Pathological changes of liver one year later in CHB patients with negative HBV DNA

BACKGROUND: In this study, we aim to determine the hepatic pathological changes in HBV DNA-negative chronic Hepatitis B (CHB) patients after 12-month antiviral therapy. METHODS: Blood routine indicators including platelet count (PLT) and white blood cell (WBC) were determined. The coagulation functi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shanshan, Wu, Xinfang, Du, Shuihong, Yu, Kecong, Lai, Jinjin, Qi, Zhi, Chen, Feng, Chen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902453/ https://www.ncbi.nlm.nih.gov/pubmed/31827599 http://dx.doi.org/10.1186/s13027-019-0265-2

Ejemplares similares

Expression changes of Tim-3 as one of supplementary indicators for monitoring prognosis of liver pathological changes in chronic HBV infection
por: Wu, Shanshan, et al.
Publicado: (2022)

Virologic and clinical characteristics of HBV genotypes/subgenotypes in 487 Chinese pediatric patients with CHB
por: Zhong, Yan-Wei, et al.
Publicado: (2011)

Serum HBV DNA plus RNA reflecting cccDNA level before and during NAs treatment in HBeAg positive CHB patients
por: Wang, Yang, et al.
Publicado: (2022)

MAFLD is Associated with the Risk of Liver Fibrosis and Inflammatory Activity in HBeAg-Negative CHB Patients
por: Chen, Xiaoman, et al.
Publicado: (2022)

Dynamic comparison between Daan real-time PCR and Cobas TaqMan for quantification of HBV DNA levels in patients with CHB
por: Cai, Shao-hang, et al.
Publicado: (2014)

Effects of antiviral therapy on post-hepatectomy HBV reactivation and liver function in HBV DNA-negative patients with HBV-related hepatocellular carcinoma
por: Gong, Wen-Feng, et al.
Publicado: (2017)

Study on pathological and clinical characteristics of chronic HBV infected patients with HBsAg positive, HBV DNA negative, HBeAg negative
por: Zeng, Zhan, et al.
Publicado: (2023)

LECT2, A Novel and Direct Biomarker of Liver Fibrosis in Patients With CHB
por: Xu, Honghai, et al.
Publicado: (2021)

Gwen Douglas, MB ChB, FRCPsych
por: Shoenberg, Peter
Publicado: (2022)

Abnormally primed CD8 T cells: The Achilles’ heel of CHB
por: Chen, Xiaoqing, et al.
Publicado: (2023)

Effects of transarterial chemoembolization combined with antiviral therapy on HBV reactivation and liver function in HBV-related hepatocellular carcinoma patients with HBV-DNA negative
por: Wang, Kai, et al.
Publicado: (2018)

Peter Sykes MB, ChB, FRCPsych, DPM
por: Savin, Emma
Publicado: (2018)

HBsAg Dampened STING Associated Activation of NK Cells in HBeAg-Negative CHB Patients
por: Zheng, Bingqing, et al.
Publicado: (2021)

Hepatitis B Virus (HBV) Variants in Untreated and Tenofovir Treated Chronic Hepatitis B (CHB) Patients during Pregnancy and Post-Partum Follow-Up
por: Virine, Boris, et al.
Publicado: (2015)

Study on Post-Treatment Relapse in HBeAg Positive CHB Patients
por: Lu, Junfeng, et al.
Publicado: (2015)

Correction: Hepatitis B Virus (HBV) Variants in Untreated and Tenofovir Treated Chronic Hepatitis B (CHB) Patients During Pregnancy and Post-Partum Follow-up
por: Virine, Boris, et al.
Publicado: (2015)

Lynn Sinclair Gillis, MB ChB, MD, FRCPsych
por: Raphael-Leff, Joan
Publicado: (2021)

The safety concerns regarding immune checkpoint inhibitors in liver cancer patients rising mainly from CHB
por: Lou, Shike, et al.
Publicado: (2023)

Diagnostic value of angiopoietin-like protein 2 for CHB-related hepatocellular carcinoma
por: Zhou, Jiyuan, et al.
Publicado: (2019)

A comparative study of clinicopathological and imaging features of HBV-negative and HBV-positive intrahepatic cholangiocarcinoma patients with different pathologic differentiation degrees
por: Huang, Xiaoli, et al.
Publicado: (2023)

The Infection Efficiency and Replication Ability of Circularized HBV DNA Optimized the Linear HBV DNA in Vitro and in Vivo
por: Li, Xiaosong, et al.
Publicado: (2015)

The chitobiose transporter, chbC, is required for chitin utilization in Borrelia burgdorferi
por: Rhodes, Ryan G, et al.
Publicado: (2010)

Identification of the risk for liver fibrosis on CHB patients using an artificial neural network based on routine and serum markers
por: Wang, Danan, et al.
Publicado: (2010)

Altered PGE2-EP2 is associated with an excessive immune response in HBV-related acute-on-chronic liver failure
por: Wang, Yunyun, et al.
Publicado: (2019)

Clinical Outcomes and Quantitative HBV Surface Antigen Levels in Diverse Chronic Hepatitis B Patients in Canada: A Retrospective Real-World Study of CHB in Canada (REVEAL-CANADA)
por: Coffin, Carla S., et al.
Publicado: (2022)

Gamma-glutamyl-transpeptidase to platelet ratio is not superior to APRI,FIB-4 and RPR for diagnosing liver fibrosis in CHB patients in China
por: Huang, Rui, et al.
Publicado: (2017)

Correlation Between HBsAg Quantitation and HBV DNA in HBeAg-Negative HBV/D Patients
por: Teriaky, Anouar, et al.
Publicado: (2013)

Dynamic changes of HBV markers and HBV DNA load in infants born to HBsAg(+) mothers: can positivity of HBsAg or HBV DNA at birth be an indicator for HBV infection of infants?
por: Chen, Tianyan, et al.
Publicado: (2013)

Noninvasive Diagnosis of Hepatic Steatosis Using Fat Attenuation Parameter Measured by FibroTouch and a New Algorithm in CHB Patients
por: Deng, Hong, et al.
Publicado: (2016)

Circulating Neutrophil Dysfunction in HBV-Related Acute-on-Chronic Liver Failure
por: Wu, Wei, et al.
Publicado: (2021)

The relationship between the clearance of HBsAg and the remodeling of B cell subsets in CHB patients treated with Peg-IFN-α
por: Wu, Ze-Qian, et al.
Publicado: (2021)

Elevated liver fibrosis index FIB-4 is not reliable for HCC risk stratification in predominantly non-Asian CHB patients
por: Demir, Münevver, et al.
Publicado: (2016)

Correspondence on Editorial regarding “HBV pgRNA and HBcrAg reductions at week 4 predict favourable HBsAg response upon long-term nucleos(t)ide analogue in CHB”
por: Mak, Lung-Yi, et al.
Publicado: (2023)

Audit of vancomycin and gentamicin dosing and monitoring in Connolly Hospital Blanchardstown (CHB) 2014
por: Armstrong, Laura, et al.
Publicado: (2015)

A simple algorithm for non-invasive diagnosis of significant liver histological changes in patients with CHB and normal or mildly elevated alanine transaminase levels
por: Li, Qiang, et al.
Publicado: (2019)

Immune drivers of HBsAg loss in HBeAg-negative CHB patients after stopping nucleotide analog and administration of Peg-IFN
por: Islam, Mojahidul, et al.
Publicado: (2023)

Cloning, Expression, and Characterization of a Novel Thermophilic Monofunctional Catalase from Geobacillus sp. CHB1
por: Jia, Xianbo, et al.
Publicado: (2016)

The Sterile Inflammation in the Exacerbation of HBV-Associated Liver Injury
por: Yang, Qiao, et al.
Publicado: (2015)

Using machine learning models to predict HBeAg seroconversion in CHB patients receiving pegylated interferon‐α monotherapy
por: Shang, Hongyan, et al.
Publicado: (2022)

Host immunity and HBV S gene mutation in HBsAg-negative HBV-infected patients
por: Liu, Xin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hpvehernu2qcresevm3uagh5k6